THC - Tenet Healthcare Corporation

NYSE - NYSE Delayed Price. Currency in USD
20.54
-1.45 (-6.59%)
At close: 4:01PM EST
Stock chart is not supported by your current browser
Previous Close21.99
Open21.80
Bid17.32 x 800
Ask22.33 x 1800
Day's Range19.87 - 21.84
52 Week Range16.61 - 39.74
Volume2,215,223
Avg. Volume1,494,554
Market Cap2.105B
Beta (3Y Monthly)2.06
PE Ratio (TTM)N/A
EPS (TTM)-1.11
Earnings DateFeb 25, 2019 - Mar 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2000-03-13
1y Target Est26.62
Trade prices are not sourced from all markets
  • Business Wire13 hours ago

    Tenet Announces Pricing of its Upsized Private Offering of Senior Secured Notes to Refinance $1.52 Billion in Outstanding Notes

    Tenet Healthcare Corporation (THC) established today the pricing of the previously announced private offering of newly issued notes to refinance $1.52 billion of its currently outstanding notes. The offering consists of $1.50 billion aggregate principal amount of senior secured second lien notes due 2027, which will bear interest at a rate of 6.25% per annum, to be issued by Tenet (the “notes”). The size of the offering was increased from the previously announced $750 million aggregate principal amount of notes.

  • Moody's18 hours ago

    Tenet Healthcare Corporation -- Moody's rates Tenet Healthcare's senior secured second lien notes Ba3

    Moody's Investors Service (Moody's) assigned a Ba3 rating to Tenet Healthcare Corporation's ("Tenet") new senior secured second lien notes due 2027. There is no change to Tenet's existing B2 Corporate Family Rating, B2-PD Probability of Default Rating, Ba3 first lien senior secured rating, Ba3 second lien senior secured rating and Caa1 unsecured rating. Proceeds from the new $750 million of senior secured second lien notes will be used in combination with cash to repay its March 2019 unsecured notes at maturity and finance the redemption of its February 2020 unsecured notes.

  • Business Wireyesterday

    Tenet Announces Private Offering of Senior Secured Notes to Refinance $768 Million in Outstanding Notes

    Tenet Healthcare Corporation (THC) intends to refinance $768 million of its currently outstanding notes by offering to sell $750 million of newly issued notes through a private placement. The offering consists of $750 million in aggregate principal amount of newly issued senior secured second lien notes due 2027 issued by Tenet (the “notes”). Tenet intends to use a portion of the net proceeds from the sale of the notes, after payment of fees and expenses, to fund the redemption and discharge of all $300 million outstanding aggregate principal amount of its 6.75% Senior Unsecured Notes due February 1, 2020.

  • UnitedHealth Gains on Strong 4Q Results, 2019 Looks Favorable
    Zacks7 days ago

    UnitedHealth Gains on Strong 4Q Results, 2019 Looks Favorable

    UnitedHealth (UNH) shares gained following a strong fourth-quarter results, operating fundamentals point to a solid 2019

  • Business Wire7 days ago

    Tenet and Anthem Blue Cross Sign Multi-Year Agreement

    Tenet Healthcare Corporation and Anthem Blue Cross today announced that they have signed a new multi-year agreement, providing Anthem Blue Cross members with continued in-network access to Tenet’s California facilities and other providers.

  • UnitedHealth (UNH) Beats on 4Q Earnings, Keeps 2019 Guidance
    Zacks8 days ago

    UnitedHealth (UNH) Beats on 4Q Earnings, Keeps 2019 Guidance

    UnitedHealth's (UNH) fourth-quarter results gain from higher revenues and membership.

  • Markit8 days ago

    See what the IHS Markit Score report has to say about Tenet Healthcare Corp.

    # Tenet Healthcare Corp ### NYSE:THC View full report here! ## Summary * Perception of the company's creditworthiness is negative but improving * Bearish sentiment is low ## Bearish sentiment Short interest | Positive Short interest is low for THC with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $5.68 billion over the last one-month into ETFs that hold THC are among the highest of the last year, but the rate of growth is slowing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap | Negative The current level displays a negative indicator with a strengthening bias over the past 1-month. Although THC credit default swap spreads are decreasing, they are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wire8 days ago

    Tenet and Humana Sign Multi-Year Agreement

    Tenet Healthcare Corporation and Humana Inc. today announced that they have signed a new multi-year agreement, providing Humana members with in-network access to Tenet’s hospitals, outpatient centers and employed physicians.

  • American City Business Journals14 days ago

    Central Florida Regional Hospital names new CEO

    Trey Abshier will take over next month as the CEO of Central Florida Regional Hospital. Abshier will lead for-profit HCA Healthcare Inc.'s (NYSE: HCA) 221-bed hospital in Sanford. Abshier previously was CEO of Dallas-based Tenet Healthcare Corp.'s (NYSE: THC) Palm Beach Gardens Medical Center in Palm Beach Gardens and CEO of Tenent's Florida Medical Center in Fort Lauderdale.

  • Business Wire20 days ago

    Tenet to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 8, 2019

    Tenet Healthcare Corporation will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 8, 2019. Ron Rittenmeyer, Executive Chairman and CEO, will deliver a presentation at the conference at approximately 11:30 a.m.

  • Tenet Health and Cigna reach multi-year agreement
    American City Business Journals21 days ago

    Tenet Health and Cigna reach multi-year agreement

    Health insurer Cigna (NYSE: CI) and Tenet Healthcare Corp. (NYSE: THC) have reached a new agreement that will allow patients at Brookwood Baptist Health to continue receiving in-network coverage from Cigna. Financial terms of the new multi-year agreement were not disclosed. As we've previously reported, Cigna and Tenet had been negotiating a new agreement for a contract that was scheduled to expire at the end of 2018.

  • Tenet (THC) Signs Deal to Provide Services to Cigna Members
    Zacks21 days ago

    Tenet (THC) Signs Deal to Provide Services to Cigna Members

    Tenet (THC) enters new agreements to provide in-network access to Cigna members

  • Business Wire22 days ago

    Tenet Reaches Agreement with Cigna on Multi-Year Contract

    Tenet Healthcare Corporation today announced that it has signed a new, multi-year agreement with Cigna Corporation. The agreement provides Cigna members covered under its commercial health plans with uninterrupted in-network access to Tenet providers, including hospitals, outpatient centers and employed physicians.

  • Challenges Facing Health Care Stocks in 2019
    Investopedialast month

    Challenges Facing Health Care Stocks in 2019

    Health care stocks, traditionally viewed as safe havens during periods of broader market volatility, have pulled back sharply after being the strongest performer in the S&P 500 index in 2018. The Health Care Select Sector SPDR Fund (XLV) exchange-traded fund is the oldest and largest fund in the segment.

  • Hospital Industry Outlook: High Cost, Shift of Care Pose Concerns
    Zackslast month

    Hospital Industry Outlook: High Cost, Shift of Care Pose Concerns

    Hospital Industry Outlook: High Cost, Shift of Care Pose Concerns

  • HCA Houston Healthcare taps Plano exec as new chief development officer
    American City Business Journalslast month

    HCA Houston Healthcare taps Plano exec as new chief development officer

    HCA Houston Healthcare, part of Nashville, Tennessee-based HCA Healthcare Inc. (NYSE: HCA), named Chris Osentowski as the division's new chief development officer. Osentowski most recently served as the CDO of HCA-affiliated hospital Medical City Plano for a year and has been with HCA Healthcare since 2015, according to a Dec. 20 press release. Prior to joining HCA Healthcare, Osentowski worked with British pharmaceutical company GlaxoSmithKline LLC in Dallas, per the release.

  • Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?
    Zackslast month

    Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?

    Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.

  • Dow Jones Today: Nike, Goldman Sachs, Johnson & Johnson Fall Sharply
    Investor's Business Dailylast month

    Dow Jones Today: Nike, Goldman Sachs, Johnson & Johnson Fall Sharply

    Major stock indexes sold off again Monday. In the Dow Jones today, big decliners included Nike, Goldman Sachs and Johnson & Johnson.

  • 5 Healthcare Stocks That Are Feeling Sick
    InvestorPlacelast month

    5 Healthcare Stocks That Are Feeling Sick

    Shares of Johnson & Johnson (NYSE:JNJ) have fallen below their 200-day moving average to return to levels not seen since August, down nearly 13% from the highs seen in early December. Analysts are looking for earnings of $1.95 per share on revenues of $20.2 billion. Gilead Sciences (NASDAQ:GILD) shares are down 16% from the highs set in early October, a double-top high that now sets up a possible violation of the May lows that would put the mid-2017 levels near $60 in play — which would be worth a 10% drop from current levels.

  • Healthcare Battered By Texas ACA Ruling
    Zackslast month

    Healthcare Battered By Texas ACA Ruling

    Healthcare Battered By Texas ACA Ruling

  • Healthcare Stocks Take a Hit on Texas ACA Ruling
    Zackslast month

    Healthcare Stocks Take a Hit on Texas ACA Ruling

    Throwing out ACA as healthcare law in the U.S. would create plenty of tremors within the healthcare industry -- to say nothing of Insurance, Pharmaceuticals and related business sectors.

  • ObamaCare Ruling Won't Affect Coverage Yet, But Hospitals, Health Insurers Tumble
    Investor's Business Dailylast month

    ObamaCare Ruling Won't Affect Coverage Yet, But Hospitals, Health Insurers Tumble

    Hospital stocks like HCA and Medicaid insurer stocks such as Cenente fell sharply Monday folllowing a Friday night ObamaCare ruling striking down the law.

  • ACCESSWIRElast month

    Today's Research Reports on Trending Tickers: Innovate Biopharmaceuticals and Tenet Healthcare

    NEW YORK, NY / ACCESSWIRE / December 17, 2018 / Innovate Biopharmaceuticals and Tenet Healthcare Corporation both had high activity days on Friday despite any news from the companies. While shares of Innovate ...

  • Do Analysts See Any Upside for DaVita Stock?
    Market Realistlast month

    Do Analysts See Any Upside for DaVita Stock?

    Of the ten analysts covering DaVita (DVA), five have given it “buy” or higher ratings, four have given it “holds,” and one has given it a “sell.”

  • Understanding DaVita’s Operational Performance
    Market Realistlast month

    Understanding DaVita’s Operational Performance

    In the third quarter, DaVita’s (DVA) patient care and other costs rose YoY (year-over-year) to $2.06 billion from $1.95 billion. Its gross margin expanded YoY to 27.52% from 25.41%. Expected trends